Cytotoxic T-lymphocytes-associated antigen-4 (CTLA-4), programmed cell death-1 (PD-1), and programmed cell death ligand-1 (PD-L1) are well-known immune checkpoint modulators and are implemented for cancer treatment [2,3]. Here, CTLA4 is linked to cancer.